Irritable Bowel, Irritable Bowel Syndrome, Irritable Bowel Syndrome Aggravated, Irritable Bowel Syndrome Characterised by Alternating Bowel Habit, Irritable Bowel Syndrome Characterized by Constipation, Irritable Bowel Syndrome Mixed, Irritable Bowel Syndrome With Constipation, Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome Without Diarrhea
Conditions
Brief summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Detailed description
The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to IBS.
Interventions
There is no intervention for this study
Sponsors
Study design
Eligibility
Inclusion criteria
1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study a. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent 2. Male or female of all ages 3. Diagnosis of IBS
Exclusion criteria
1. Refusal to sign informed consent form 2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy. 3. Postoperative stoma, ostomy, or ileoanal pouch 4. Participation in any experimental drug protocol within the past 12 weeks 5. Treatment with total parenteral nutrition
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing | Three years | Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized with diabetes mellitus |
Countries
United States